Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;76(1):237-239.
doi: 10.1016/j.jhep.2021.07.034. Epub 2021 Aug 3.

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!

Affiliations
Comment

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!

Maria Guarino et al. J Hepatol. 2022 Jan.
No abstract available

Keywords: COVID-19; Sars-CoV-2 vaccination; immunosuppression; liver transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest No personal or financial conflicts of interest for all the authors. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Comment on

References

    1. Rabinowich L., Grupper A., Baruch R., Ben-Yehoyada M., Halperin T., Turner D., et al. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol. 2021;75(2):435–438. - PMC - PubMed
    1. Boyarsky B.J., Werbel W.A., Avery R.K., Tobian A.A.R., Massie A.B., Segev D.L., et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021 Jun 1;325(21):2204–2206. - PMC - PubMed
    1. Malinis M., Cohen E., Azar M.M. Effectiveness of SARS-CoV-2 vaccination in fully-vaccinated solid organ transplant recipients. Am J Transplant. 2021 Jun 8 doi: 10.1111/ajt.16713. - DOI - PMC - PubMed
    1. Miele M., Busà R., Russelli G., Sorrentino M.C., Di Bella M., Timoneri F., et al. Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients. Am J Transplant. 2021 May 31 doi: 10.1111/ajt.16702. - DOI - PMC - PubMed
    1. Werbel W.A., Boyarsky B.J., Ou M.T., Massie A.B., Tobian A.A.R., Garonzik-Wang J.M., et al. Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Ann Intern Med. 2021 Jun 15 doi: 10.7326/L21-0282. - DOI - PMC - PubMed

Substances